Anti-inflammatory effects of the chinese herbal formula sini tang in myocardial infarction rats

Evidence-based Complementary and Alternative Medicine

Volumn 2014, Issue , 2014, Pages

  Liu, Jiangang ^a   Peter, Karoline ^b   Shi, Dazhuo ^a   Zhang, Lei ^a   Dong, Guoju ^a   Zhang, Dawu ^a   Breiteneder, Heimo ^b   Bauer, Rudolf ^c   Jakowitsch, Johannes ^b   Ma, Yan ^b  

^a XIYUAN HOSPITAL   (China)

^b UNIVERSITY OF VIENNA   (Austria)

^c UNIVERSITY OF GRAZ   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ACONITINE; ANTIINFLAMMATORY AGENT; ATRIAL NATRIURETIC FACTOR; C REACTIVE PROTEIN; CHINESE DRUG; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENDOTHELIN 1; FOSINOPRIL; HYPACONITINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESACONITINE; NITRIC OXIDE; PENICILLIN DERIVATIVE; SINI TANG; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ACONITUM CARMICHAELII; ACUTE HEART INFARCTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CINNAMOMUM CASSIA; CONTROLLED STUDY; ECHOCARDIOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GINGER; GLYCYRRHIZA URALENSIS; HEART; HEART FAILURE; HEART FUNCTION; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE NECROSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; VASCULITIS;

EID: 84896476209     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2014/309378     Document Type: Article

References (50)

1. López-Sendón J., The heart failure epidemic. Medicographia 2011 33 363 369
2. Steg P. G., James S. K., Atar D., Badano L. P., Blomstrom-Lundqvist C., ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. European Heart Journal 2012 33 2569 2619
3. Frangogiannisa N. G., Smithb C. W., Entmana L. M., The inflammatory response in myocardial infarction. Cardiovascular Research 2002 53 31 47
4. Mehta J. L., Li D. Y., Inflammation in ischemic heart disease: response to tissue injury or a pathogenetic villain? Cardiovascular Research 1999 43 2 291 299 2-s2.0-0033179216 10.1016/S0008-6363(99)00132-7 (Pubitemid 29356367)
5. Morishima I., Sone T., Tsuboi H., Kondo J., Mukawa H., Kamiya H., Hieda N., Okumura K., Plasma C-reactive protein predicts left ventricular remodeling and function after a first acute anterior wall myocardial infarction treated with coronary angioplasty: comparison with brain natriuretic peptide. Clinical Cardiology 2002 25 3 112 116 2-s2.0-0036189366 (Pubitemid 34188707)
6. Berton G., Cordiano R., Palmieri R., Pianca S., Pagliara V., Palatini P., C-reactive protein in acute myocardial infarction: association with heart failure. American Heart Journal 2003 145 6 1094 1101 2-s2.0-0037606191 10.1016/S0002-8703(03)00098-X (Pubitemid 36688263)
7. Nian M., Lee P., Khaper N., Liu P., Inflammatory cytokines and postmyocardial infarction remodeling. Circulation Research 2004 94 12 1543 1553 2-s2.0-3042702881 10.1161/01.RES.0000130526.20854.fa (Pubitemid 38856961)
8. Tian J., Observation of treatment on 105 acute myocardial infarction patients using Si Ni Tang. Tian Jin Medical Reports 1972 11 16 20
9. Li G., Qi W., Xiong K., Clinical observation on 51 patients of acute myocardial infarction treated with thrombolytic therapy combined with Chinese herbal medicine. Chinese Journal of Integrated Traditional and Western Medicine 1999 19 8 461 462 2-s2.0-0033180674
10. Wang Z.-T., Wang S.-R., Zhao M.-J., Comparative study on effect of recipe for activating blood circulation and replenishing Qi on left ventricular remodeling in rats with left heart failure after myocardial infarction. Chinese Journal of Integrated Traditional and Western Medicine 2002 22 5 376 378 2-s2.0-0037795621
11. He Z., Wu Y., Jiang M.-X., Cheng R.-Q., Shen R., Observation by color doppler ultrasound on endothelium-dependent dilation of congestive heart failure treated with Kanli Decoction. Journal of Chinese Integrative Medicine 2004 2 4 268 270 2-s2.0-16644399312
12. Li Y. F., Cao F. F., Liu F., Bai X. Y., Lu Y., Effects of Shexiangbaoxin pills on the expression of cardiac alpha (1)- and beta-adrenergic receptor subtypes in rat hearts with heart failure induced by myocardial infarction. Chinese Medical Journal 2012 125 1556 1562
13. Luo J., Xu H., Outcome measures of chinese herbal medicine for coronary heart disease: an overview of systematic reviews. Evidence-Based Complementary and Alternative Medicine 2012 2012 9 10.1155/2012/927392 927392
14. Zhang Z., Shang Han Lun (Discussion of Cold-Induced Disorders) 2005 Public Health Press
15. Dietl W., Trescher K., Hohensinner P., SiNiTang-a traditional Chinese herbal remedy improves cardiac function post-MI. Journal of Clinical & Experimental Cardiology 2012 5 1 4
16. Peter K K., Schinnerl J., Felsinger S., Brecker L., Bauer R., Breiteneder H., Xu R., Ma Y., A novel concept for detoxification: complexation between aconitine and liquiritin in a Chinese herbal formula ("Sini Tang"). Journal of Ethnopharmacology 2013 149 562 569
17. Boyd J. H., Mathur S., Wang Y., Bateman R. M., Walley K. R., Toll-like receptor stimulation in cardiomyoctes decreases contractility and initiates an NF- B dependent inflammatory response. Cardiovascular Research 2006 72 3 384 393 2-s2.0-33750515851 10.1016/j.cardiores.2006.09.011 (Pubitemid 44665856)
18. Arslan F., Smeets M. B., O'Neill L. A. J., Keogh B., McGuirk P., Timmers L., Tersteeg C., Hoefer I. E., Doevendans P. A., Pasterkamp G., De Kleijn D. P. V., Myocardial ischemia/reperfusion injury is mediated by leukocytic toll-like receptor-2 and reduced by systemic administration of a novel anti-toll-like receptor-2 antibody. Circulation 2010 121 1 80 90 2-s2.0-74549178528 10.1161/CIRCULATIONAHA.109.880187
19. Favre J., Musette P., Douin-Echinard V., Laude K., Henry J.-P., Arnal J.-F., Thuillez C., Richard V., Toll-like receptors 2-deficient mice are protected against postischemic coronary endothelial dysfunction. Arteriosclerosis, Thrombosis, and Vascular Biology 2007 27 5 1064 1071 2-s2.0-34247363161 10.1161/ATVBAHA.107.140723 (Pubitemid 46641958)
20. Oyama J.-I., Blais C. Jr., Liu X., Pu M., Kobzik L., Kelly R. A., Bourcier T., Reduced myocardial ischemia-reperfusion injury in toll-like receptor 4-deficient mice. Circulation 2004 109 6 784 789 2-s2.0-1242336786 10.1161/01.CIR.0000112575.66565.84 (Pubitemid 38222900)
21. Llorens S., Jordán J., Nava E., The nitric oxide pathway in the cardiovascular system. Journal of Physiology and Biochemistry 2002 58 3 179 188 2-s2.0-0036770255 (Pubitemid 36192882)
22. Toblli J. E., DiGennaro F., Giani J. F., Dominici F. P., Nebivolol: impact on cardiac and endothelial function and clinical utility. Vascular Health and Risk Management 2012 8 151 160
23. Boyer B., Hart K. W., Sperling M. I., Lindsell C. J., Collins S. P., Biomarker changes during acute heart failure treatment. Congestive Heart Failure 2012 18 2 91 97 2-s2.0-84858799239 10.1111/j.1751-7133.2011.00256.x
24. Dietz J. R., Mechanisms of atrial natriuretic peptide secretion from the atrium. Cardiovascular Research 2005 68 1 8 17 2-s2.0-24644445690 10.1016/j.cardiores.2005.06.008 (Pubitemid 41268613)
25. Cannone V., Huntley B. K., Olson T. M., Heublein D. M., Scott C. G., Bailey K. R., Redfield M. M., Rodeheffer R. J., Burnett J. C. Jr., Atrial natriuretic peptide genetic variant rs5065 and risk for cardiovascular disease in the general community: a 9-year follow-up study. Hypertension 2013 62 5 860 865
26. Gaggin H. K., James L., Januzzi J. L. Jr., Biomarkers and diagnostics in heart failure. Biochimica et Biophysica Acta 2013 1832 12 2442 2450
27. Kolettis T. M., Barton M., Langleben D., Matsumura Y., Endothelin in coronary artery disease and myocardial infarction. Cardiology in Review 2013 21 5 249 256
28. Borghi C., Marino P., Zardini P., Magnani B., Collatina S., Ambrosioni E., Short- and long-term effects of early fosinopril administration in patients with acute anterior myocardial infarction undergoing intravenous thrombolysis: results from the Fosinopril in Acute Myocardial Infarction Study. American Heart Journal 1998 136 2 213 225 2-s2.0-0031820940
29. Bicket D. P., Using ACE inhibitors appropriately. American Family Physician 2002 66 3 461 473 2-s2.0-0036682696
30. Berezin A. E., Effect of fosinopril on the rate of neurohumoral and proinflammatory activation in patients with heart failure. Klinicheskaia Meditsina 2004 82 9 29 32 2-s2.0-16644384811
31. Resources I., Guide for the Care and Use of Laboratory Animals 1996 Washington, DC, USA Commission on Life Sciences, National Research Council. National Academy Press
32. Csupor D., Wenzig E. M., Zupkó I., Wölkart K., Hohmann J., Bauer R., Qualitative and quantitative analysis of aconitine-type and lipo-alkaloids of Aconitum carmichaelii roots. Journal of Chromatography A 2009 1216 11 2079 2086 2-s2.0-60349087777 10.1016/j.chroma.2008.10.082
33. Pfeffer J. M., Pfeffer M. A., Fletcher P. J., Braunwald E., Ventricular performance in rats with myocardial infarction and failure. American Journal of Medicine 1984 76 99 103 2-s2.0-0021274127 (Pubitemid 14106352)
34. Yin H.-J., Zhang Y., Jiang Y.-R., Effect of folium panax quinquefolium saponins on apoptosis of cardiac muscle cells and apoptosis-related gene expression in rats with acute myocardial infarction. Chinese Journal of Integrated Traditional and Western Medicine 2005 25 3 232 235 2-s2.0-22144482029
35. Yin H.-J., Zhang Y., Jiang Y.-R., Effect of folium panax quinquefolium saponins on apoptosis of cardiac muscle cells and apoptosis-related gene expression in rats with acute myocardial infarction. Chinese Journal of Integrated Traditional and Western Medicine 2005 25 3 232 235 2-s2.0-22144482029
36. Koren M. J., Devereux R. B., Casale P. N., Savage D. D., Laragh J. H., Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Annals of Internal Medicine 1991 114 5 345 352 2-s2.0-0026092229
37. Wu A.-M., Zhao M.-J., Zhang D.-M., Characteristics of TCM syndrome and appraisal with echocardiography in heart failure rats after myocardial infarction. Chinese Journal of Integrated Traditional and Western Medicine 2007 27 3 227 230 2-s2.0-43049175258
38. Takagawa J., Zhang Y., Wong M. L., Sievers R. E., Kapasi N. K., Wang Y., Yeghiazarians Y., Lee R. J., Grossman W., Springer M. L., Myocardial infarct size measurement in the mouse chronic infarction model: comparison of area- and length-based approaches. Journal of Applied Physiology 2007 102 6 2104 2111 2-s2.0-34447526684 10.1152/japplphysiol.00033.2007 (Pubitemid 47080740)
39. Panteghini M., Role and importance of biochemical markers in clinical cardiology. European Heart Journal 2004 25 14 1187 1196 2-s2.0-3042706302 10.1016/j.ehj.2004.04.026 (Pubitemid 38891568)
40. Sato Y., Fujiwara H., Takatsu Y., Biochemical markers in heart failure. Journal of Cardiology 2012 59 1 1 7 2-s2.0-84855197004 10.1016/j.jjcc.2011.11. 001
41. Chung V. C., Chen M., Ying Q., Tam W. W., Wu X. Y., Ma P. H., Ziea E. T., Wong V. C., Tang J. L., Add-on effect of chinese herbal medicine on mortality in myocardial infarction: systematic review and meta-analysis of randomized controlled trials. Evidence-Based Complementary and Alternative Medicine 2013 2013 12 10.1155/2013/675906 675906
42. Evangelista A., Flachskampf F., Lancellotti P., Badano L., Aguilar R., Monaghan M., Zamorano J., Nihoyannopoulos P., European Association of Echocardiography recommendations for standardization of performance, digital storage and reporting of echocardiographic studies. European Journal of Echocardiography 2008 9 4 438 448 2-s2.0-45849110596 10.1093/ejechocard/jen174 (Pubitemid 351882129)
43. Yang X., Chong Z., Guo Y., The regulating effects of Sinitang on vasoactive substance in rats with renal hypertension. Chinese Journal of Clinical Pharmacy 2008 28
44. Kapadia S. R., Oral H., Lee J., Nakano M., Taffet G. E., Mann D. L., Hemodynamic regulation of tumor necrosis factor-gene and protein expression in adult feline myocardium. Circulation Research 1997 81 2 187 195 2-s2.0-0030794617 (Pubitemid 27342485)
45. Fan Q., Science of prescriptions. A Newly Compiled Practical English-Chinese Library of Traditional Chinese Medicine 2002 Publishing House of Shanghai University of Traditional Chinese Medicine 94 96
46. Lantz R. C., Chen G. J., Sarihan M., Sólyom A. M., Jolad S. D., Timmermann B. N., The effect of extracts from ginger rhizome on inflammatory mediator production. Phytomedicine 2007 14 2-3 123 128 2-s2.0-33846394444 10.1016/j.phymed.2006.03.003 (Pubitemid 46136942)
47. Ueda H., Ippoushi K., Takeuchi A., Repeated oral administration of a squeezed ginger (Zingiber officinale) extract augmented the serum corticosterone level and had anti-inflammatory properties. Bioscience, Biotechnology and Biochemistry 2010 74 11 2248 2252 2-s2.0-78649772566 10.1271/bbb.100456
48. Hwa J. S., Jin Y. C., Lee Y. S., Ko Y. S., Kim Y. M., Shi L. Y., Kim H. J., Lee J. H., Ngoc T. M., Bae K. H., Kim Y. S., Chang K. C., 2-methoxycinnamaldehyde from Cinnamomum cassia reduces rat myocardial ischemia and reperfusion injury in vivo due to HO-1 induction. Journal of Ethnopharmacology 2012 139 2 605 615 2-s2.0-84856013387 10.1016/j.jep.2011.12. 001
49. Siracusa L., Saija A., Cristani M., Cimino F., D'Arrigo M., Trombetta D., Rao F., Ruberto G., Phytocomplexes from liquorice (Glycyrrhiza glabra L.) leaves-chemical characterization and evaluation of their antioxidant, anti-genotoxic and anti-inflammatory activity. Fitoterapia 2011 82 4 546 556 2-s2.0-79955476022 10.1016/j.fitote.2011.01.009
50. Kim S.-W., Jin Y., Shin J.-H., Kim I.-D., Lee H.-K., Park S., Han P.-L., Lee J.-K., Glycyrrhizic acid affords robust neuroprotection in the postischemic brain via anti-inflammatory effect by inhibiting HMGB1 phosphorylation and secretion. Neurobiology of Disease 2012 46 1 147 156 2-s2.0-84858149685 10.1016/j.nbd.2011.12.056